Azitra, Inc. AZTR on NYSE
This company's Exchange Act registration has been revoked
This company's Exchange Act registration as a Municipal Advisor has been revoked
This company's Exchange Act registration as a Municipal Advisor has been cancelled
[+] Company Information
CIK:
0001701478
0001701478
EIN:
46-4478536
46-4478536
LEI:
(CF Office: 03 Life Sciences)
Business address:
21 BUSINESS PARK DRIVE, SUITE 6, BRANFORD, CT, 06405
Phone: (203) 489-0183
21 BUSINESS PARK DRIVE, SUITE 6, BRANFORD, CT, 06405
Phone: (203) 489-0183
Mailing address:
21 BUSINESS PARK DRIVE, SUITE 6, BRANFORD, CT, 06405
21 BUSINESS PARK DRIVE, SUITE 6, BRANFORD, CT, 06405
Category:
Emerging growth company
Emerging growth company
Former names:
- Azitra Inc - filings through 2024-01-04
Filings:
142 EDGAR filings since March 20, 2017
142 EDGAR filings since March 20, 2017
Get insider transactions
for this issuer
Get insider transactions
for this reporting owner
Latest Filings (excluding insider transactions)
- May 2, 2025 - 424B5: Prospectus [Rule 424(b)(5)] Open documentClick to Open document FilingOpen filingClick to Open filing
- May 2, 2025 - 8-K: Current report Open documentClick to Open document FilingOpen filingClick to Open filing
- 5.08 - Shareholder Director Nominations
- May 1, 2025 - EFFECT: Notice of Effectiveness Open documentClick to Open document FilingOpen filingClick to Open filing
- April 28, 2025 - S-1: General form for registration of securities under the Securities Act of 1933 Open documentClick to Open document FilingOpen filingClick to Open filing
- April 24, 2025 - 8-K: Current report Open documentClick to Open document FilingOpen filingClick to Open filing
- 1.01 - Entry into a Material Definitive Agreement
- 3.02 - Unregistered Sales of Equity Securities
- 8.01 - Other Events (The registrant can use this Item to report events that are not specifically called for by Form 8-K, that the registrant considers to be of importance to security holders.)
- 9.01 - Financial Statements and Exhibits
Selected Filings
[+] 8-K (current reports)
- May 2, 2025 - 8-K: Current report Open documentClick to Open document FilingOpen filingClick to Open filing
- 5.08 - Shareholder Director Nominations
- April 24, 2025 - 8-K: Current report Open documentClick to Open document FilingOpen filingClick to Open filing
- 1.01 - Entry into a Material Definitive Agreement
- 3.02 - Unregistered Sales of Equity Securities
- 8.01 - Other Events (The registrant can use this Item to report events that are not specifically called for by Form 8-K, that the registrant considers to be of importance to security holders.)
- 9.01 - Financial Statements and Exhibits
- February 24, 2025 - 8-K: Current report Open documentClick to Open document FilingOpen filingClick to Open filing **Earnings release**
- 2.02 - Results of Operations and Financial Condition
- 9.01 - Financial Statements and Exhibits
- February 20, 2025 - 8-K: Current report Open documentClick to Open document FilingOpen filingClick to Open filing
- 5.07 - Submission of Matters to a Vote of Security Holders
- February 6, 2025 - 8-K: Current report Open documentClick to Open document FilingOpen filingClick to Open filing
- 1.01 - Entry into a Material Definitive Agreement
- 3.02 - Unregistered Sales of Equity Securities
- 9.01 - Financial Statements and Exhibits
- February 6, 2025 - 8-K: Current report Open documentClick to Open document FilingOpen filingClick to Open filing
- 1.01 - Entry into a Material Definitive Agreement
- 8.01 - Other Events (The registrant can use this Item to report events that are not specifically called for by Form 8-K, that the registrant considers to be of importance to security holders.)
- 9.01 - Financial Statements and Exhibits
[+] 10-K (annual reports) and 10-Q (quarterly reports)
- February 24, 2025 - 10-K: Annual report for year ending December 31, 2024Open documentClick to Open document FilingOpen filingClick to Open filing
- November 12, 2024 - 10-Q: Quarterly report for quarter ending September 30, 2024Open documentClick to Open document FilingOpen filingClick to Open filing
- August 12, 2024 - 10-Q: Quarterly report for quarter ending June 30, 2024Open documentClick to Open document FilingOpen filingClick to Open filing
- May 9, 2024 - 10-Q: Quarterly report for quarter ending March 31, 2024Open documentClick to Open document FilingOpen filingClick to Open filing
[+] Proxy (annual meeting) and information statements
- January 14, 2025 - DEF 14A: Other definitive proxy statements Open documentClick to Open document FilingOpen filingClick to Open filing
- January 3, 2025 - PRE 14A: Other preliminary proxy statements Open documentClick to Open document FilingOpen filingClick to Open filing
- October 9, 2024 - DEF 14A: Other definitive proxy statements Open documentClick to Open document FilingOpen filingClick to Open filing
[+] Ownership disclosures
- Insider transactions
No insider transaction filings for this company in last 365 days
- Beneficial ownership (Schedule 13D and 13G)
- February 14, 2025 - SCHEDULE 13G/A: Schedule filed by certain investors to report beneficial ownership of more than 5% of a class of equity securities - amendmentOpen documentClick to Open document FilingOpen filingClick to Open filing
- November 14, 2024 - SC 13G/A: Statement of acquisition of beneficial ownership by individuals - amendmentOpen documentClick to Open document FilingOpen filingClick to Open filing
- November 14, 2024 - SC 13G/A: Statement of acquisition of beneficial ownership by individuals - amendmentOpen documentClick to Open document FilingOpen filingClick to Open filing
Filings
| Form type | Form description | Filing date | Reporting date |
|---|
0
Showing 1 to 20 of 142 entries
Data source:
CIK0001701478.json
There is no filings data for
this organization
Investor Resources
How to Use EDGAR
Learn how to use EDGAR to research public filings by public companies, mutual funds, ETFs, some annuities, and more.
Before you Invest, Investor.gov
Get answers to your investing questions from the SEC's website dedicated to retail investors
